Virtue Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.84M	Buy	54,595 +1,181	+2%	+$202K	1.34%	15
2025 Q4	$9.03M	Buy	+53,414	New	+$8.68M	1.39%	15
2023 Q4	–	Sell	-1,725	Closed	-$219K	–	397
2023 Q3	$219K	Hold	1,725	–	–	0.04%	363
2023 Q2	$219K	Sell	1,725 -8,328	-83%	-$1.08M	0.04%	360
2023 Q1	$1.29M	Buy	+10,053	New	+$1.32M	0.21%	78
2022 Q2	–	Sell	-8,709	Closed	-$1.14M	–	339
2022 Q1	$1.14M	Buy	8,709 +971	+13%	+$126K	0.18%	140
2021 Q4	$1.18M	Sell	7,738 -2,983	-28%	-$462K	0.17%	157
2021 Q3	$1.73M	Buy	10,721 +332	+3%	+$55.9K	0.31%	71
2021 Q2	$1.7M	Buy	10,389 +3,150	+44%	+$485K	0.34%	65
2021 Q1	$1.09M	Sell	7,239 -227	-3%	-$36.1K	0.26%	121
2020 Q4	$1.13M	Buy	7,466 +2,957	+66%	+$423K	0.28%	112
2020 Q3	$611K	Buy	+4,509	New	+$612K	0.15%	185